Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | LSS | P48449 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2863882 | 1.00 | PTPN1 (0.43) | PTPN1LSSTDP1KDM1AFDFT1 | |
| SCHEMBL28820216 | 0.86 | PTPN1 (0.55) | PTPN1LSSTDP1KDM1AFDFT1 | |
| SCHEMBL2861896 | 0.81 | LSS (0.46) | PTPN1LSSFDFT1 | |
| SCHEMBL2861895 | 0.81 | LSS (0.46) | PTPN1LSSFDFT1 | |
| SCHEMBL2855424 | 0.80 | LSS (0.51) | LSSFDFT1 | |
| SCHEMBL2855422 | 0.80 | LSS (0.51) | LSSFDFT1 | |
| SCHEMBL2867890 | 0.78 | LSS (0.38) | PTPN1LSSFDFT1 | |
| SCHEMBL2867892 | 0.78 | LSS (0.38) | PTPN1LSSFDFT1 | |
| SCHEMBL2866506 | 0.77 | TDP1 (0.40) | PTPN1LSSTDP1 | |
| SCHEMBL2866508 | 0.77 | TDP1 (0.40) | PTPN1LSSTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728180-B2 | Method for producing ethers | KURARAY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080262272-A1 | Method For Producing Ethers | KURARAY CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1760061-A1 | METHOD FOR PRODUCING ETHERS | KURARAY CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262272-A1 | Method For Producing Ethers | TELO2, PDS5A, TERT | PTPN1 2589/4885LSS 1302/4885TDP1 2332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.